日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Evaluation of c-Abl inhibitor vodobatinib in subjects with early Parkinson's disease: a phase 2, randomized, double-blind, placebo-controlled study

评估 c-Abl 抑制剂 vodobatinib 在早期帕金森病患者中的疗效:一项 2 期随机、双盲、安慰剂对照研究

Sarva, Harini; Pahwa, Rajesh; Hernandez-Vara, Jorge; Goldstein, Mark A; Borgohain, Rupam; Factor, Stewart A; Inamdar, Sandeep; Love, Damon; Hames, Carrie; Fu, Yiyong; Mergel, Victor; Goldfine, Andrew; Kumar, Chandra; Piccoli, Steven P; Yao, Siu-Long; Hurko, Orest

Level of eHealth Literacy and Its Associations With Health Behaviors and Outcomes in Chinese Older Adults: Cross-Sectional Analysis of Baseline Data From a Large-Scale Community Project

中国老年人电子健康素养水平及其与健康行为和结果的关联:一项大型社区项目基线数据的横断面分析

Chau, Siu Long; He, Wanjia; Luk, Tzu Tsun; Chan, Sophia Siu Chee

University students' perspectives on delivering health education interventions to underprivileged older adults in the community: a qualitative study of a large-scale community-based research project

大学生对向社区弱势老年人提供健康教育干预的看法:一项大型社区研究项目的定性研究

Chau, Siu Long; He, Wanjia; Chan, Sophia Siu Chee

A Brief Intervention With Instant Messaging or Regular Text Messaging Support in Reducing Alcohol Use: A Randomized Clinical Trial

即时通讯或常规短信支持的简短干预对减少酒精使用的影响:一项随机临床试验

Chau, Siu Long; Luk, Tzu Tsun; Wong, Benney Yiu Cheong; Wu, Yongda Socrates; Cheung, Yee Tak Derek; Ho, Sai Yin; Kim, Jean H; Lo, Herman Hay Ming; Lam, Tai Hing; Wang, Man Ping

The association between loneliness and depressive symptoms among adults aged 50 years and older: a 12-year population-based cohort study

一项基于人群的12年队列研究探讨了50岁及以上成年人孤独感与抑郁症状之间的关联。

Lee, Siu Long; Pearce, Eiluned; Ajnakina, Olesya; Johnson, Sonia; Lewis, Glyn; Mann, Farhana; Pitman, Alexandra; Solmi, Francesca; Sommerlad, Andrew; Steptoe, Andrew; Tymoszuk, Urszula; Lewis, Gemma

Mobile chat-based support plus nicotine replacement therapy sampling to promote smoking cessation for community smokers: A randomized controlled trial

利用移动聊天支持和尼古丁替代疗法试用装促进社区吸烟者戒烟:一项随机对照试验

Zhao, Sheng Zhi; Wu, Yongda Socrates; Chau, Siu Long; Fong, Daniel Yee Tak; Lam, Tai Hing; Wang, Man Ping

A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma

SCH 717454(robatumumab)治疗复发性骨肉瘤和尤文氏肉瘤患者的II期临床活性研究

Anderson, Peter M; Bielack, Stefan S; Gorlick, Richard G; Skubitz, Keith; Daw, Najat C; Herzog, Cynthia E; Monge, Odd R; Lassaletta, Alvaro; Boldrini, Erica; Pápai, Zsuzanna; Rubino, Joseph; Pathiraja, Kumudu; Hille, Darcy A; Ayers, Mark; Yao, Siu-Long; Nebozhyn, Michael; Lu, Brian; Mauro, David

Fifteen-year Outcomes Following Conservative Management Among Men Aged 65 Years or Older with Localized Prostate Cancer

65岁及以上局限性前列腺癌男性患者保守治疗15年后的疗效

Lu-Yao, Grace L; Albertsen, Peter C; Moore, Dirk F; Lin, Yong; DiPaola, Robert S; Yao, Siu-Long

Fifteen-year survival outcomes following primary androgen-deprivation therapy for localized prostate cancer

局部前列腺癌患者接受原发性雄激素剥夺疗法后的15年生存结果

Lu-Yao, Grace L; Albertsen, Peter C; Moore, Dirk F; Shih, Weichung; Lin, Yong; DiPaola, Robert S; Yao, Siu-Long

A first-in-human, phase 1, dose-escalation study of dinaciclib, a novel cyclin-dependent kinase inhibitor, administered weekly in subjects with advanced malignancies

一项首次人体试验的 I 期剂量递增研究,评估了新型细胞周期蛋白依赖性激酶抑制剂 dinaciclib 每周一次给药治疗晚期恶性肿瘤患者的疗效。

Nemunaitis, John J; Small, Karen A; Kirschmeier, Paul; Zhang, Da; Zhu, Yali; Jou, Ying-Ming; Statkevich, Paul; Yao, Siu-Long; Bannerji, Rajat